US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Atomo Diagnostics Limited (AT1) 銘柄情報

Atomo Diagnostics Limited (AT1)

0.016

-0.001

(-5.88%)

終了 6月27日 3:00PM

Atomo Diagnostics Limited (AT1) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.016

( -5.88% )

買値

0.016

売値

0.017

出来高

1,406,257

0.016 日の範囲 0.017

0.014 52 週間の範囲 0.048

時価総額

前日終値

0.017

始値

0.016

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,113,852

発行済株式数

902,432,853

配当利回り

PER

-3.11

1 株当たり利益 (EPS)

-0.01

歳入

3.92M

純利益

-3.98M

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics ... Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

atomodiagnostics.com

本社

Leichhardt, Australia

設立

2026

Atomo Diagnostics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker AT1. The last closing price for Atomo Diagnostics was AUD0.02. Over the last year, Atomo Diagnostics shares have traded in a share price range of AUD 0.014 to AUD 0.048.

Atomo Diagnostics currently has 902,432,853 shares in issue. The market capitalisation of Atomo Diagnostics is AUD14.44 million. Atomo Diagnostics has a price to earnings ratio (PE ratio) of -3.11.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.002	-11.1111111111	0.018	0.02	0.016	1390790	0.01837636	DE
4	-0.004	-20	0.02	0.0205	0.016	1174734	0.0181413	DE
12	-0.017	-51.5151515152	0.033	0.033	0.016	1768123	0.02467447	DE
26	-0.021	-56.7567567568	0.037	0.048	0.016	1848333	0.0317739	DE
52	0	0	0.016	0.048	0.014	1714137	0.02800824	DE
156	-0.004	-20	0.02	0.1	0.014	1270544	0.03342263	DE
260	-0.124	-88.5714285714	0.14	0.3725	0.014	1266047	0.09780855	DE

AT1 - Frequently Asked Questions (FAQ)

What is the current Atomo Diagnostics Limited share price?

The current share price of Atomo Diagnostics Limited is AUD 0.016

How many Atomo Diagnostics Limited shares are in issue?

Atomo Diagnostics Limited has 902,432,853 shares in issue

What is the market cap of Atomo Diagnostics Limited?

The market capitalisation of Atomo Diagnostics Limited is AUD 14.44M

What is the 1 year trading range for Atomo Diagnostics Limited share price?

Atomo Diagnostics Limited has traded in the range of AUD 0.014 to AUD 0.048 during the past year

What is the PE ratio of Atomo Diagnostics Limited?

The price to earnings ratio of Atomo Diagnostics Limited is -3.11

What is the cash to sales ratio of Atomo Diagnostics Limited?

The cash to sales ratio of Atomo Diagnostics Limited is 3.91

What is the registered address of Atomo Diagnostics Limited?

The registered address for Atomo Diagnostics Limited is 3-5 George Street, Leichhardt, New South Wales, 2040

What is the Atomo Diagnostics Limited website address?

The website address for Atomo Diagnostics Limited is atomodiagnostics.com

Which industry sector does Atomo Diagnostics Limited operate in?

Atomo Diagnostics Limited operates in the Medical Equipment & Supplies sector

WHITTENHALLJR

WHITTENHALLJR 6分前

Some for me … I know we’ll be at .02 soon … no fear to by up

ExtremelyBullishZig

ExtremelyBullishZig 6分前

Right!
Principal and Chief are the same thing.

meirluc

meirluc 7分前

"If approval does depend on the build-out of the C suite
But even if the answer to the question is "NO" is it not also possible that they have determined to wait for the completion of the C suite before approval - EVEN IF NOT REQUIRED? (perhaps to simplify or eliminate future regulatory actio

learningcurve2020

learningcurve2020 7分前

Those financiers need a reverse split to make it profitable again solely for physiological reasons.

watcher777

watcher777 9分前

I've spent so much time researching this company and have met with the CEO, CFO and also shook professor Li's hand and at this point I have no trust in any of their ability to be transparent. However, they may very well do great things but I don't think they have us in mind.

MrBobbob

MrBobbob 9分前

Ronnie Replay

Ronnie Replay 11分前

Wonder how Hi_Lo is feeling right now lol.

12yearplan

12yearplan 12分前

Would fit a common pattern.

Southern Gal

Southern Gal 12分前

looking strong again

Dragonman1

Dragonman1 14分前

Bashers are hard at Work trying to destroy stocks!

joe botts

joe botts 15分前

Wow!!!! Howd you know? Spot on, geez what a genius! Oh no NOW what do I do? Lmao!!!!

Dragonman1

Dragonman1 16分前

Don' sell that is your answer!

High_Desert

High_Desert 18分前

Hi, new guy here, bought some TGLO a few years ago. What is the realistic upside value of this stock in say 5-7 years if things go right? I know, impossible to accurately answer, but just any thoughts if you have them.

waterchaser

waterchaser 19分前

Thank you satter for keeping us up-to-date…
on HIRU’s legal messes.
I don’t have the ability (or maybe acumen) to offer what you do.
Kudos.
.

88TH MAN

88TH MAN 19分前

Maybe we should let a jury decide that? BULLISH!!!

Dragonman1

Dragonman1 20分前

Your a paid basher bro!

Dragonman1

Dragonman1 22分前

hat is not true, If the have investors the are golden! PDIV would not increase their stake in this Co if they didn't believe in them, hahaha to the bashers, you will be Done!

DJurg

lol ...the $0.5M number means the current ATM magazine is almost empty. It does not mean the dilution gun is out of ammo.

FCEL has a fresh shelf mechanism (June 8th filing) and a 1 billion authorized-share ceiling, with only roughly 68 million shares outstanding as of June 1. So they

mascale

mascale 37分前

Soon likely no longer a mining stock(?), (@nickeli54).

✅ Annual report any time now

✅ Audit progress

✅ Continued share buybacks

✅ Acquisition updates

✅ Hollywood Star Cuts expansion

JamesF1

JamesF1 37分前

Praxgen was NOT Sun Pharma. Sun Pharma is a huge multinational company. Praxgen was formerly known as Sungen. I’m guessing the name change may have been to avoid confusion (and legal issues) between the two companies.

ysung

Holy f k !!!!!
Finally real useful update !!!!!!!

Guido2

Guido2 40分前

https://x.com/guidoperei/status/2070666466693943488?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ

wshaw14

wshaw14 41分前

No news in a while.We should be hearing something soon.

LegendaryOracle941

LegendaryOracle941 43分前

I guess all of the potential stock holders are eagerly waiting for some kind of positive news coming from the new ownership ( as we all know that with a proper planning ) this empty shell stock will be a gold mine in the future ( keep all of the shares in contact)

Atomo Diagnostics

Croma Security Solutions

Latin Resources

Lightspeed Commerce

Velocity Composites

JPMorgan Chase & Co.

Latitude Consolidated

Javelin Minerals

Armada Mercantile

Simplify Vettafi Private...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。